Loading clinical trials...
Loading clinical trials...
This clinical trial studies how well delayed fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) works in improving visualization of brain tumors in patients wit...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jonsson Comprehensive Cancer Center
NCT07539441 · Central Nervous System Tumors, Glioma
NCT03206060 · Pheochromocytoma, Paraganglioma, and more
NCT04065776 · Glioma, Pilocytic Astrocytoma, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT05636618 · Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, and more
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions